Amarin Corp Plc (AMRN)

[KCSVEN]

Seems initial comments I read on patents was not totally accurate once details were out so main reason for drop is either, mis-information on AMRN patent protection or 100% related to fear generics will take main market share and Lovaza and Vascepa will be left with scraps.

Not concerned with that,Pretty clear to me that Marine market is lower than everyone estimated, If Teva thinks they are entering a 1 billion dollar market with a generic they will be sorely mistaken as I'm convinced Lovaza does 70% of sales in Anchor population.

Of course On the initial look nothing positive about having generic Lovaza to compete against us accept GHK perhaps pursuing AMRN and GSK not spending any advertising dollars or efforts on Lovaza. By time Teva gets a ruling, courts finalize everything, Teva moves to production and selling AMRN should be near Anchor approval and sales anyways. I don't call it a non-event or positive but not a 8-10% drop event for sure.

The reality is Anchor market by itself is worth a 5 billion market cap and AMRN will have that to itself soon enough.

Partnership should be the #1 option, by FAR, for Anchor. They get a partner for Anchor we will be 15 or so heading into new year, they don't and us holders will be waiting until Q 2 2014 sales to make much hay.